Published in Sex Transm Dis on March 01, 1999
Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Recurrent Bacterial Vaginosis. Curr Infect Dis Rep (2000) 1.06
Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial. PLoS Clin Trials (2007) 1.01
The rationale for probiotics in female urogenital healthcare. MedGenMed (2004) 0.88
Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol (2001) 0.86
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol (2006) 0.82
Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study. J Low Genit Tract Dis (2015) 0.79
Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure. Eur J Clin Microbiol Infect Dis (2014) 0.76
Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora. Sci Rep (2016) 0.76
Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencing. BMC Genomics (2016) 0.75
Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis (2017) 0.75
Benefits and potential harm of lowering high blood pressure. Lancet (1987) 4.88
A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med (1996) 4.36
A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76
Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol (1991) 3.30
The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA (1990) 2.91
Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis (2001) 2.86
Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55
The vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynecol (1996) 2.41
Criteria for diagnosis and grading of salpingitis. Obstet Gynecol (1983) 2.37
Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol (1987) 2.11
Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun (1980) 2.11
Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol (1999) 2.10
Vertical transmission of hepatitis C virus. Lancet (1991) 2.08
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA (1986) 2.06
The use of mesh in gynecologic surgery. Int Urogynecol J Pelvic Floor Dysfunct (1997) 2.05
Pelvic inflammatory disease in human immunodeficiency virus-infected women. Obstet Gynecol (1993) 2.05
Determinants of participation in an epidemiological study of preterm delivery. Paediatr Perinat Epidemiol (1999) 2.01
Diagnosis of male Chlamydia trachomatis urethritis by polymerase chain reaction. Sex Transm Dis (1995) 1.94
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination. Lancet (1984) 1.91
Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol (1990) 1.83
Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr (1985) 1.81
Management of genital herpes infection in pregnancy. Obstet Gynecol (1988) 1.80
Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract (1985) 1.75
Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol (1994) 1.72
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.70
Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. Am J Obstet Gynecol (1991) 1.67
Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. Am J Obstet Gynecol (1973) 1.67
High-frequency (10-18 kHz) hearing thresholds: reliability, and effects of age and occupational noise exposure. Occup Med (Lond) (2001) 1.62
Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest (2001) 1.61
Bacteroides species as a cause of severe infections in obstetric and gynecologic patients. Surg Gynecol Obstet (1971) 1.60
PROPERTIES AND BIOLOGICAL BEHAVIOUR OF COOMASSIE BLUE. Br Heart J (1959) 1.59
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesth Analg (1993) 1.58
Entonox® inhalation to reduce pain in common diagnostic and therapeutic outpatient urological procedures: a review of the evidence. Ann R Coll Surg Engl (2012) 1.58
Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.56
Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis (1983) 1.55
Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections. Obstet Gynecol (1979) 1.54
The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA (1986) 1.54
Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions. Clin Chim Acta (1970) 1.53
Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52
Dynamic urethral pressure profilometry pressure transmission ratio: what do the numbers really mean? Obstet Gynecol (1991) 1.48
Puerperal infectious morbidity: a two-year review. Am J Obstet Gynecol (1973) 1.46
Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. Am J Obstet Gynecol (1994) 1.46
Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA (1983) 1.46
Chorioamnionitis, not epidural analgesia, is associated with maternal fever during labour. Can J Anaesth (2001) 1.46
Evidence of RPGRIP1 gene mutations associated with recessive cone-rod dystrophy. J Med Genet (2003) 1.44
Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol (1989) 1.42
The natural history of thrombocytopenia associated with preeclampsia. Am J Obstet Gynecol (1990) 1.39
Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis (1985) 1.39
Management of radial keratotomy overcorrections by corneal sutures. J Cataract Refract Surg (1993) 1.39
Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet Gynecol (1994) 1.37
Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med (1986) 1.36
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. Gynecol Oncol (2000) 1.33
Smoking and pregnancy outcome among African-American and white women in central North Carolina. Epidemiology (2001) 1.31
Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertens (1987) 1.31
In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrob Agents Chemother (1982) 1.30
Urinary tract infections in pregnancy. Urol Clin North Am (1999) 1.29
Risk factors for pelvic inflammatory disease. A case control study. Sex Transm Dis (1996) 1.28
Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials (1998) 1.27
Pelvic inflammatory disease: etiology, diagnosis, and treatment. Sex Transm Dis (1982) 1.27
Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA (1985) 1.27
Occupational noise exposure and hearing loss of workers in two plants in eastern Saudi Arabia. Ann Occup Hyg (2001) 1.26
Inhibition of Neisseria gonorrhoeae attachment to HeLa cells with monoclonal antibody directed against a protein II. Infect Immun (1983) 1.26
The use of graft materials in vaginal pelvic floor surgery. Int J Gynaecol Obstet (2006) 1.26
Polymerase chain reaction analysis of distal vaginal specimens: a less invasive strategy for detection of Trichomonas vaginalis. Clin Infect Dis (1997) 1.26
Anaerobic infections of the female genital tract. Am J Obstet Gynecol (1975) 1.24
Chlamydial salpingitis and infertility. Fertil Steril (1982) 1.23
Diagnosis and classification of abnormal lipoprotein patterns. Clin Chim Acta (1971) 1.23
Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol (2001) 1.23
Acute salpingitis in the adolescent female. J Pediatr (1982) 1.23
A novel locus for Leber congenital amaurosis (LCA4) with anterior keratoconus mapping to chromosome 17p13. Invest Ophthalmol Vis Sci (2000) 1.23
The use of parenteral clindamycin in the treatment of obstetric-gynecologic patients with severe infections. A comparison of a clindamycin-kanamycin combination with penicillin-kanamycin. Obstet Gynecol (1974) 1.23
A randomized controlled trial of smoking cessation intervention in pregnancy in an academic clinic. Obstet Gynecol (1996) 1.22
Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo. Epidemiol Infect (2008) 1.22
Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol (2001) 1.21
MR imaging of levator ani muscle recovery following vaginal delivery. Int Urogynecol J Pelvic Floor Dysfunct (1999) 1.18
Pelvic inflammatory disease and its sequelae in adolescents. J Adolesc Health Care (1985) 1.17
Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol (1993) 1.17
Typhoid fever in pregnancy. A case report. J Reprod Med (1990) 1.16
Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor. J Steroid Biochem Mol Biol (2000) 1.15
Urinary tract infections. Clin Obstet Gynecol (1998) 1.15
Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate. Biochem Pharmacol (1966) 1.15
Antibiotic use during pregnancy and the postpartum period. Clin Obstet Gynecol (1983) 1.14
Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature. Arch Surg (1983) 1.14
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J Steroid Biochem Mol Biol (2001) 1.13
Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis (1999) 1.12
Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. Lancet (1972) 1.11
Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis (1993) 1.09
Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc (1989) 1.09
Long-term sequelae of acute pelvic inflammatory disease. A retrospective cohort study. Am J Obstet Gynecol (1992) 1.08
Identification of novel mutations in the SEMA4A gene associated with retinal degenerative diseases. J Med Genet (2005) 1.08
Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol (1979) 1.08
Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA (1991) 1.08
Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab (1980) 1.06
Gonococcal infection in a nonhuman host is determined by human complement C1q. Infect Immun (1995) 1.06
Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology (1998) 1.06
Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol (1983) 1.06